Virax Biolabs Group Limited

VRAXNASDAQ·USD·Closed

VRAXNASDAQ·USD·Closed

$2.62

−6.43%

$2.62

−$0.18 (6.43%)

52W Range

1thpctl

Volume

0.03×avg

Mkt Cap

488958USD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.03×avg

Market Cap

488958USD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-96.0% / yr

Operating margin-51515.2%

ROIC-82.6%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage-103.6×

Current ratio9.97×